Development and Validation for Taiwan Version ID Pain Questionnaire (ID Pain-T) and DN4 Questionnaire.

Verified by: Pfizer, November 2009
First Received: January 11, 2008 | Last Updated: November 19, 2009 | Phase: N/A | Start Date: March 2008
Overall Status: Completed | Estimated Enrollment: 325
  • …
  • Tell a FriendPrint

This prospective cohort and multi-site study aims to develop Taiwan version (ID Pain-T) based on the original versions of ID Pain and also DN4, and validate both ID Pain-T and DN4 applied in Taiwanese subjects at the clinical setting...

Brief Summary

Official Title: “Development and Validation for Taiwan Version ID Pain Questionnaire (ID Pain-T) and DN4 Questionnaire.”

This prospective cohort and multi-site study aims to develop Taiwan version (ID Pain-T) based on the original versions of ID Pain and also DN4, and validate both ID Pain-T and DN4 applied in Taiwanese subjects at the clinical setting.

  • Study Type: Observational
  • Study Design: Observational Model: Case-Only, Time Perspective: Prospective
  • Study Primary Completion Date: December 2008

Intervention(s) in this Clinical Trial

  • Other: ID-Pain DN4 Questionnaire
    • This is a non-interventional questionnaire validation study

Outcome Measures for this Clinical Trial

Primary Measures

  • Determine the optimal cut-off score of ID Pain-T Questionnaire for screening of neuropathic pain
    • Time Frame: end of study
      Safety Issue?: No

Secondary Measures

  • Evaluate the predictive power of ID Pain-T Questionnaire for diagnosis of neuropathic pain
    • Time Frame: end of study
      Safety Issue?: No
  • Develop and evaluate validity of a short form diagnostic tool based on DN4 structure
    • Time Frame: end of study
      Safety Issue?: No

Criteria for Participation in this Clinical Trial

Inclusion Criteria:

  • Subjects without headache pain over 30 days and at least 18 years old who will visit the clinic, inclusive of male and female.
  • Subjects who are able to complete the ID Pain-T Questionnaire.

Exclusion Criteria:

  • Subjects who are illiterate or unable to complete questionnaire.
  • Subjects who are currently participating in another study or have participated in another pain study within one month of study entry.
  • Subjects with low back pain are unable to participate in this study; as the sciatica caused by the piriformis (exclusive of the other types of sciatic pain), lumbago, unclear identification in nerve injury (e.g. complex regional pain syndrome type I) or mixed origin (e.g. cancer pain).

Gender Eligibility for this Clinical Trial: Both

Minimum Age for this Clinical Trial: 18 Years

Maximum Age for this Clinical Trial: N/A

Are Healthy Volunteers Accepted for this Clinical Trial?: No

Clinical Trial Investigator Information

Lead Investigator: Pfizer Industry

Overall Clinical Trial Officials and Contacts

Pfizer CT.gov Call Center Study Director Pfizer  

Additional Information

Information obtained from ClinicalTrials.gov on February 12, 2012

Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00599768

Study ID Number: A0081175

ClinicalTrials.gov Identifier: NCT00599768

Health Authority: Taiwan: Department of Health

To obtain contact information for a study center near you, click here.

  • …
  • Tell a FriendPrint

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00599768